Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine in Bipolar Depression
NCT01093963Phase 3Terminated
- Sponsor
- Lindner Center of HOPE
- Start
- Jan 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lisdexamfetamine in bipolar disorder (BD), sponsored by Lindner Center of HOPE. Started Jan 2010; status: terminated.
02
Drugs
lisdexamfetamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01093963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093963.